Clinical Trial Update: Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms [NA]

View source ↗

Summary

A pilot trial evaluating a WT-1 analog peptide vaccine in patients with myeloid neoplasms has completed enrollment and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• WT-1 analog peptide vaccine (WT-1 peptide vaccine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Leukemia | NA | Status: COMPLETED | Results posted: 2014-07-24